Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
7.53M
-
Shares change
-
-176K
-
Total reported value, excl. options
-
$90.5M
-
Value change
-
-$6.01M
-
Number of buys
-
31
-
Number of sells
-
-25
-
Price
-
$12.03
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q4 2018
65 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q4 2018.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.53M shares
of 48M outstanding shares and own 15.66% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (2.43M shares), SANDLER CAPITAL MANAGEMENT (968K shares), Vanguard Group Inc (557K shares), RENAISSANCE TECHNOLOGIES LLC (444K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (434K shares), Schonfeld Strategic Advisors LLC (337K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (308K shares), CADENCE CAPITAL MANAGEMENT LLC (192K shares), First Eagle Investment Management, LLC (178K shares), and BlackRock Inc. (153K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.